|
JAMA Oncology |
Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors |
1 |
Yes |
5/20/2024 |
|
JAMA Oncology |
Effects of Exercise on Cardiorespiratory Fitness and Biochemical Progression in Men With Localized Prostate Cancer Under Active Surveillance |
1 |
Yes |
10/21/2024 |
|
JAMA Oncology |
Efficacy and Safety of Stereotactic Radiosurgery for Brainstem Metastases |
1 |
Yes |
7/15/2024 |
|
JAMA Oncology |
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida |
1 |
Yes |
3/18/2025 |
|
JAMA Oncology |
Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer |
1 |
Yes |
11/5/2024 |
|
JAMA Oncology |
Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant |
1 |
Yes |
4/22/2025 |
|
JAMA Oncology |
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease |
1 |
Yes |
4/21/2025 |
|
JAMA Oncology |
Global Association of COVID-19 Pandemic Measures With Cancer Screening - A Systematic Review and Meta-analysis |
1 |
Yes |
8/1/2025 |
|
JAMA Oncology |
Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors |
1 |
Yes |
3/17/2025 |
|
JAMA Oncology |
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients |
1 |
Yes |
3/18/2025 |
|
JAMA Oncology |
Identification of Deaths Caused by Cancer and COVID-19 in the US During March to December 2020 |
1 |
Yes |
10/26/2025 |
|
JAMA Oncology |
Immune Responses to SARS-CoV-2 Among Patients With Cancer - What Can Seropositivity Tell Us? |
1 |
Yes |
6/4/2024 |
|
JAMA Oncology |
Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination |
1 |
Yes |
8/4/2024 |
|
JAMA Oncology |
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer |
1 |
Yes |
9/23/2025 |
|
JAMA Oncology |
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates |
1 |
Yes |
12/16/2024 |
|
JAMA Oncology |
Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors |
1 |
Yes |
4/22/2025 |
|
JAMA Oncology |
Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors |
1 |
Yes |
1/20/2025 |
|
JAMA Oncology |
Neoadjuvant Endocrine Therapy in Clinical Practice |
1 |
Yes |
11/18/2024 |
|
JAMA Oncology |
Painful Eruptions in a Patient With Cholangiocarcinoma Treated With Fibroblast Growth Factor Receptor Inhibitor |
1 |
Yes |
10/28/2024 |
|
JAMA Oncology |
Pancytopenia in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor After Peptide Receptor Radionuclide Therapy |
1 |
Yes |
4/29/2024 |
